338
Gèze A, Chau LT, Choisnard L, Mathieu JP, Marti-Batlle D, Riou L, Putaux JL, Wouessidjewe D
(2007) Biodistribution of intravenously administered amphiphilic β-cyclodextrin nanospheres.
Int J Pharm 344:135–142. https://doi.org/10.1016/j.ijpharm.2007.06.050
Ghera BB, Perret F, Chevalier Y, Parrot-Lopez H (2009) Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and
application to the transport of acyclovir. Int J Pharm 22:155–162. https://doi.org/10.1016/j.
ijpharm.2009.04.004
Gil ES, Li J, Xiao H, Lowe TL (2009) Quaternary ammonium β-cyclodextrin nanoparticles for
enhancing doxorubicin permeability across the in vitro blood-brain barrier. Biomacromolecules
10:505–516. https://doi.org/10.1021/bm801026k
Godinho BMDC, Ogier JR, Darcy R, O’Driscoll CM, Cryan JF (2013) Self-assembling modified
β-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on Huntington’s disease. Mol Pharm 10:640–649. https://doi.org/10.1021/mp3003946
Godinho BMDC, Ogier JR, Quinlan A, Darcy R, Griffin BT, Cryan JF, Caitriona MOD (2014)
PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene
glycol length and nanoparticle stability. Int J Pharm 473:105–112. https://doi.org/10.1016/j.
ijpharm.2014.06.054
Gonzalez H, Hwang SJ, Davis ME (1999) New class of polymers for the delivery of macromolecular therapeutics. Bioconjug Chem 10:1068–1074. https://doi.org/10.1021/bc990072j
Gooding M, Malhotra M, McCarthy DJ, Godinho BMDC, Cryan JF, Darcy R, O’Driscoll CM
(2015) Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis. Eur J Pharm Sci
71:80–92. https://doi.org/10.1016/j.ejps.2015.02.007
Gorjikhah F, Azizi Jalalian F, Salehi R, Panahi Y, Hasanzadeh A, Alizadeh E, Akbarzadeh A,
Davaran S (2017) Preparation and characterization of PLGA-β-cyclodextrin polymeric
nanoparticles containing methotrexate and evaluation of their effects on T47D cell line. Artif
Cells Nanomed Biotechnol 45:432–440. https://doi.org/10.3109/21691401.2016.1160915
Guo J, Ogier JR, Desgranges S, Darcy R, ODriscoll C (2012) Anisamide-targeted cyclodextrin
nanoparticles for siRNA delivery to prostate tumours in mice. Biomaterials 33:7775–7784.
https://doi.org/10.1016/j.biomaterials.2012.07.012
Guo B, Xu D, Liu X, Liao C, Li S, Huang Z, Li X, Yi J (2017) Characterization and cytotoxicity
of PLGA nanoparticles loaded with formononetin cyclodextrin complex. J Drug Delivery Sci
Technol 41:375–383. https://doi.org/10.1016/j.jddst.2017.08.010
Ha W, Kang Y, Peng SL, Ding LS, Zhang S, Li BJ (2013) Vesicular gold assemblies based on
host- guest inclusion and its controllable release of doxorubicin. Nanotechnology 24. https://
doi.org/10.1088/0957-4484/24/49/495103
Hamada H, Ishihara K, Masuoka N, Mikuni K, Nakajima N (2006) Enhancement of water- solubility
and bioactivity of paclitaxel using modified cyclodextrins. J Biosci Bioeng 102:369–371.
https://doi.org/10.1263/jbb.102.369
He M, Zhong C, Hu H, Jin Y, Chen Y, Lou K, Gao F (2019) Cyclodextrin/chitosan nanoparticles
for oral ovalbumin delivery: preparation, characterization and intestinal mucosal immunity in
mice. Asian J Pharm Sci 14:193–203. https://doi.org/10.1016/j.ajps.2018.04.001
Hippalgaonkar K, Adelli GR, Hippalgaonkar K, Repka MA, Majumdar S (2013) Indomethacinloaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro
evaluation. J Ocul Pharmacol Ther 29:216–228. https://doi.org/10.1089/jop.2012.006
Holzinger M, Bouffier L, Villalonga R, Cosnier S (2009) Adamantane/β-cyclodextrin affinity biosensors based on single-walled carbon nanotubes. Biosens Bioelectron 24:1128–1134. https://
doi.org/10.1016/j.bios.2008.06.029
Hou X, Zhang W, He M, Lu Y, Lou K, Gao F (2017) Preparation and characterization of
β-cyclodextrin grafted N-maleoyl chitosan nanoparticles for drug delivery. Asian J Pharm Sci
12:558–568. https://doi.org/10.1016/j.ajps.2017.07.007
A. Pandey
Gèze A, Chau LT, Choisnard L, Mathieu JP, Marti-Batlle D, Riou L, Putaux JL, Wouessidjewe D
(2007) Biodistribution of intravenously administered amphiphilic β-cyclodextrin nanospheres.
Int J Pharm 344:135–142. https://doi.org/10.1016/j.ijpharm.2007.06.050
Ghera BB, Perret F, Chevalier Y, Parrot-Lopez H (2009) Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: preparation, characterization and
application to the transport of acyclovir. Int J Pharm 22:155–162. https://doi.org/10.1016/j.
ijpharm.2009.04.004
Gil ES, Li J, Xiao H, Lowe TL (2009) Quaternary ammonium β-cyclodextrin nanoparticles for
enhancing doxorubicin permeability across the in vitro blood-brain barrier. Biomacromolecules
10:505–516. https://doi.org/10.1021/bm801026k
Godinho BMDC, Ogier JR, Darcy R, O’Driscoll CM, Cryan JF (2013) Self-assembling modified
β-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on Huntington’s disease. Mol Pharm 10:640–649. https://doi.org/10.1021/mp3003946
Godinho BMDC, Ogier JR, Quinlan A, Darcy R, Griffin BT, Cryan JF, Caitriona MOD (2014)
PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene
glycol length and nanoparticle stability. Int J Pharm 473:105–112. https://doi.org/10.1016/j.
ijpharm.2014.06.054
Gonzalez H, Hwang SJ, Davis ME (1999) New class of polymers for the delivery of macromolecular therapeutics. Bioconjug Chem 10:1068–1074. https://doi.org/10.1021/bc990072j
Gooding M, Malhotra M, McCarthy DJ, Godinho BMDC, Cryan JF, Darcy R, O’Driscoll CM
(2015) Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis. Eur J Pharm Sci
71:80–92. https://doi.org/10.1016/j.ejps.2015.02.007
Gorjikhah F, Azizi Jalalian F, Salehi R, Panahi Y, Hasanzadeh A, Alizadeh E, Akbarzadeh A,
Davaran S (2017) Preparation and characterization of PLGA-β-cyclodextrin polymeric
nanoparticles containing methotrexate and evaluation of their effects on T47D cell line. Artif
Cells Nanomed Biotechnol 45:432–440. https://doi.org/10.3109/21691401.2016.1160915
Guo J, Ogier JR, Desgranges S, Darcy R, ODriscoll C (2012) Anisamide-targeted cyclodextrin
nanoparticles for siRNA delivery to prostate tumours in mice. Biomaterials 33:7775–7784.
https://doi.org/10.1016/j.biomaterials.2012.07.012
Guo B, Xu D, Liu X, Liao C, Li S, Huang Z, Li X, Yi J (2017) Characterization and cytotoxicity
of PLGA nanoparticles loaded with formononetin cyclodextrin complex. J Drug Delivery Sci
Technol 41:375–383. https://doi.org/10.1016/j.jddst.2017.08.010
Ha W, Kang Y, Peng SL, Ding LS, Zhang S, Li BJ (2013) Vesicular gold assemblies based on
host- guest inclusion and its controllable release of doxorubicin. Nanotechnology 24. https://
doi.org/10.1088/0957-4484/24/49/495103
Hamada H, Ishihara K, Masuoka N, Mikuni K, Nakajima N (2006) Enhancement of water- solubility
and bioactivity of paclitaxel using modified cyclodextrins. J Biosci Bioeng 102:369–371.
https://doi.org/10.1263/jbb.102.369
He M, Zhong C, Hu H, Jin Y, Chen Y, Lou K, Gao F (2019) Cyclodextrin/chitosan nanoparticles
for oral ovalbumin delivery: preparation, characterization and intestinal mucosal immunity in
mice. Asian J Pharm Sci 14:193–203. https://doi.org/10.1016/j.ajps.2018.04.001
Hippalgaonkar K, Adelli GR, Hippalgaonkar K, Repka MA, Majumdar S (2013) Indomethacinloaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro
evaluation. J Ocul Pharmacol Ther 29:216–228. https://doi.org/10.1089/jop.2012.006
Holzinger M, Bouffier L, Villalonga R, Cosnier S (2009) Adamantane/β-cyclodextrin affinity biosensors based on single-walled carbon nanotubes. Biosens Bioelectron 24:1128–1134. https://
doi.org/10.1016/j.bios.2008.06.029
Hou X, Zhang W, He M, Lu Y, Lou K, Gao F (2017) Preparation and characterization of
β-cyclodextrin grafted N-maleoyl chitosan nanoparticles for drug delivery. Asian J Pharm Sci
12:558–568. https://doi.org/10.1016/j.ajps.2017.07.007
A. Pandey